March 18-20, 2024 | Boston, MA

Returning for the seventh year, the 7th Antigen-Specific Immune Tolerance Summit will lean into the industry’s key challenges from details of T-cell assays in preclinical and larger clinical studies; to pioneering CAR-Treg, mRNA-LNP, biologic, peptide, approaches, and updates on proof-of-concept and ongoing clinical programs.

This is your comprehensive guide to define your pipeline and therapeutic development strategy for 2023, delve into your opportunity to create tolerizingcurative, strategies for autoimmunity, and tap into your tolerance strategy to tackle immunogenicity and transform the biologic landscape.

Joining the 100+ senior decision makers from C-level executives to senior scientists is Beacon’s Immune Tolerance expert team, set to deliver a landscape analysis of auto-antigen-specific immune tolerance therapies for autoimmune diseases. More details about the presentation can be found here or inside the full event guide.